BioSpace News Archive

Press Releases

TREMFYA® (guselkumab) receives U.S. FDA approval for adults with moderately to severely active ulcerative colitis, strengthening Johnson & Johnson’s leadership in inflammatory bowel disease

September 12, 2024
·
14 min read
Press Releases

Viridian Therapeutics Announces Pricing of Upsized Public Offering of Shares of Common Stock and Preferred Stock

September 12, 2024
·
6 min read
Press Releases

Santhera Announces Half-Year 2024 Financial Results and Provides Corporate Update

September 12, 2024
·
20 min read
Press Releases

Henry Schein Participates in the FDI World Dental Congress 2024 in Istanbul, Turkey

September 12, 2024
·
5 min read
Press Releases

Lifecore Biomedical Regains Compliance with Nasdaq Listing Requirements

September 12, 2024
·
2 min read
Press Releases

Summit Therapeutics Raises $235 Million

September 12, 2024
·
9 min read
Press Releases

Fulcrum Therapeutics Announces Topline Results from Phase 3 REACH Clinical Trial of Losmapimod in Facioscapulohumeral Muscular Dystrophy (FSHD)

September 12, 2024
·
8 min read
Press Releases

Aura Biosciences Reports Positive Phase 2 End of Study Results Evaluating Bel-sar as a First-Line Treatment for Early-Stage Choroidal Melanoma

September 12, 2024
·
8 min read
Press Releases

Oruka Therapeutics Announces $200 Million Private Placement

September 12, 2024
·
6 min read
Press Releases

Invivyd at the Ready for Upcoming Respiratory Virus Season with PEMGARDA™ (pemivibart) to Help Protect Vulnerable Immunocompromised Persons from COVID-19

September 12, 2024
·
13 min read